XML 205 R83.htm IDEA: XBRL DOCUMENT v3.22.0.1
Other disclosures - Acquisition of businesses - Fair value of recognized assets and liabilities (Details) - Dicerna Pharmaceuticals, Inc., United States
kr in Millions
Dec. 28, 2021
DKK (kr)
Disclosure of detailed information about business combination [line items]  
Intellectual property rights kr 18,687
Other intangible assets 24
Financial assets 31
Cash 3,033
Deferred tax assets/liabilities, net (3,480)
Other net assets (607)
Identifiable assets acquired (liabilities assumed) 17,688
Goodwill 4,346
Consideration transferred, acquisition-date fair value 22,034
Settlement of pre-existing relationship (145)
Fair value of equity interest before acquisition date 573
Consideration transferred 21,316
Cash transferred kr 18,283